Print Page | Contact Us
Online Store: Microbiome Webinars
Main Storefront

Microbiome Update: Clinical Protocols for Treatment in Dysbiotic Disease Series

Item Options
Sign in for your pricing!
Price: $399.00
Quantity: *

Price includes access to the Microbiome Group forum, webinar recordings, handouts, and CE certificate



Corene Humphreys, ND has a unique take on the microbiome. As the former head of the Gastroenterology Division at Genova Diagnostics, she reviewed literally thousands of stool and vaginal cultures and pioneered the development of the CDSA 2.0 stool test and other gastrointestinal and metabolic profiles. As a consultant to the probiotics industry internationally, she knows these organisms intimately and understands the benefits and limitations of industry-produced replacement flora. She will cover this in a no-holds barred lecture in her first class: "Probiotics in Clinical Practice: Scientific Evidence vs. Marketing Hype."


Corene is a registered naturopathic physician, medical herbalist, homeopath and functional medicine specialist, and we'll learn more from her clinical experience about biofilms, antibiotic resistance, treatment of irritable bowel syndrome, vaginitis, vaginosis, and other dysbiotic dilemas.


Approved for 10.75 General Credit Hours by the Oregon Board of Naturopathic Medicine

Corene Humphreys, B.H.Sc., ND

Corene Humphreys received her qualifications in Medical Microbiology from the New Zealand Institute of Medical Laboratory Technology and her ND from the South Pacific College of Natural Therapeutics. She has since worked in private and public microbiology laboratories around the world and when residing in the U.S., headed the Gastroenterology Research Department at Genova Diagnostics Lab. She has lectured internationally and acted as a consultant for functional medicine practices and companies striving to develop probiotic products.

She is currently faculty for Wellpark College in Auckland, New Zealand where she teaches microbiology and functional medicine and is the Founder and Medical Director of Nutritional Medicine Ltd., an international consulting and development firm in the business of developing natural evidence-based products and teaching functional medicine.



Probiotics in Clinical Practice: Scientific Evidence vs. Marketing Hype
Original Air Date: April 23, 2014


Probiotics as defined by the FAO/WHO are "live microorganisms that when administered in adequate amounts confer a health benefit on the host." Numerous dietary supplement companies and practitioner-only ranges sell probiotic formulations, however not all of these products met the FAO/WHO criteria. This webinar will explore the evidence behind various probiotic strains and their specific clinical indications. Attendees will also learn what constitutes an "adequate" dose along with manufacturing procedures to ensure viability, shelf stability and delivery of probiotics to targeted tissues.

The Use of Probiotics in Yeast Vaginitis & Bacterial Vaginosis
Original Air Date: April 30, 2014


Yeast vaginitis & bacterial vaginosis are common gynaecological conditions that affect most women at least once in their life time. Over-the-counter pharmacological anti-fungal medications are often used to alleviate clinical symptoms of vaginal infection without first identifying the etiological pathogen(s). The rise in use of oral and locally applied anti-fungals is thought in part to have resulted in the emergence of resistant microbial strains.

Research has revealed that certain probiotic organisms can help overcome and prevent vaginal dysbiosis when administered orally and may also help protect against urinary tract infections. This webinar will expound on the science behind the use of specific probiotic strains as a concomitant and/or alternative evidence-based approach to support and maintain a healthy vaginal flora.


Biofilms, Antibiotic Resistance and Chronic Disease
Original Air Date: May 7, 2014


Biofilms are structured and aggregated communities of bacteria that can be 100-1000 times more resistant to antibiotics than their planktonic counterparts. Chronic bacterial infections share three common features:

  1. they are difficult to diagnose;
  2. they resist activities of the body's immune defenses; and
  3. they are seldom eradicated with modern-day antimicrobials

This webinar will explore the underlying mechanisms of how biofilms communicate through quorum-sensing (QS) and control the expression of the innate immune system. Participants will also learn about the importance of diet and the use of specific botanical agents as natural QS inhibitors to help overcome chronic microbial infections.


The Role of Gut Barrier Function in Health & Disease
Original Air Date: May 14, 2014


The small intestine is a multifaceted organ involved in digestive and absorptive processes as well as protection against harmful molecules. When gut barrier function is compromised, local and systemic complications can ensue. This webinar will explore the clinical consequences that can result from a breech in gut mucosal integrity and their association with specific disease states. Attendees will also learn how to identify patients with altered gut permeability along with evidence-based pharmacological and natural agents to restore gut barrier integrity.


Functional Medicine Testing and Treatment Protocols for Irritable Bowel Syndrome, Part 1
Original Air Date: May 21, 2014


Irritable bowel syndrome (IBS) is a common medical condition in the Western world. Conventional diagnosis through meeting the ROME III criteria identifies patients with the condition, but fails to establish the underlying etiology. This seminar will explore the many different causes of IBS and their associated, subtle but unique clinical symptoms. Participants will also learn about the specific Functional and diagnostic profiles to support the differential diagnosis.


Functional Medicine Testing and Treatment Protocols for Irritable Bowel Syndrome, Part 2

Original Air Date: May 28, 2014


This webinar continues from the IBS Part 1 lecture. Once a clinician has established the underlying cause of IBS through clinical signs and symptoms and diagnostic verification, a targeted treatment plan can be implemented. This seminar will explore the different natural and evidence-based interventions available to practitioners to help restore gut homeostasis and healthy bowel function.